These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Classification of hyperlipoproteinemias]. Zabel R Dermatol Monatsschr; 1974 Feb; 160(2):134-50. PubMed ID: 4369507 [No Abstract] [Full Text] [Related]
4. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate. Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408 [No Abstract] [Full Text] [Related]
5. [Mixed hyperlipemia with a distinct accumulation of beta and prebeta lipoproteins (apropos of 78 cases)]. Loeper J; Rouffy J; Loeper J Arch Mal Coeur Vaiss; 1970-1971; 12():Suppl 1:3-15. PubMed ID: 5004789 [No Abstract] [Full Text] [Related]
7. Type-3 hyperlipoproteinaemia in a child. Godolphin WJ; Conradi G; Campbell DJ Lancet; 1972 Jan; 1(7743):209-10. PubMed ID: 4109589 [No Abstract] [Full Text] [Related]
8. [Hyperlipoproteinemias and their skin manifestations]. Zabel R Padiatr Grenzgeb; 1974; 13(2-3):99-107. PubMed ID: 4369584 [No Abstract] [Full Text] [Related]
9. On a family with coexistence of phenotypes II and III hyperlipoproteinemia. Mariën KJ; Hulsmans HA; van Gent CM Acta Med Scand; 1974 Sep; 196(3):149-53. PubMed ID: 4370577 [No Abstract] [Full Text] [Related]
10. Plasma lipoproteins and hyperlipoproteinemia. Gustafson A; Berg K Acta Med Scand; 1973 May; 193(5):369-72. PubMed ID: 4352670 [No Abstract] [Full Text] [Related]
11. Type IV hyperlipoproteinaemia. A survey based on 23 cases. Christensen NC; Horder M Dan Med Bull; 1970 Feb; 17(2):54-9. PubMed ID: 5446368 [No Abstract] [Full Text] [Related]
12. Familial hyperlipoproteinemia type 3. Fleischmajer R Arch Dermatol; 1969 Oct; 100(4):401-6. PubMed ID: 4311549 [No Abstract] [Full Text] [Related]
14. Lipid abnormalities in male and female survivors of myocardial infarction and their first-degree relatives. Patterson D; Slack J Lancet; 1972 Feb; 1(7747):393-9. PubMed ID: 4110639 [No Abstract] [Full Text] [Related]
15. Familial hypercholesterolaemia (familial hyper-beta-lipoproteinaemia or type II hyperlipoproteinaemia) in a Chinese family. Teoh PC Singapore Med J; 1973 Jun; 14(2):124-9. PubMed ID: 4741434 [No Abstract] [Full Text] [Related]
16. Familial hypercholesterolemia in a large indred. Evidence for a monogenic mechanism. Schrott HG; Goldstein JL; Hazzard WR; McGoodwin MM; Motulsky AG Ann Intern Med; 1972 May; 76(5):711-20. PubMed ID: 5025321 [No Abstract] [Full Text] [Related]
17. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate. Roe DA Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239 [No Abstract] [Full Text] [Related]
18. [Development of xanthoma in hyperlipoproteinemias]. Braun-Falco O Z Hautkr; 1975 Jun; 50(12):539-40. PubMed ID: 1199293 [No Abstract] [Full Text] [Related]
19. Secondary eruptive xanthoma. Type V hyperlipoproteinemia. Schreiber MM; Shapiro SI Arch Dermatol; 1969 Nov; 100(5):601-3. PubMed ID: 5350416 [No Abstract] [Full Text] [Related]
20. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial. Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640 [No Abstract] [Full Text] [Related] [Next] [New Search]